BDBM664432 (2R,3R,4S,5R,6R)-4-(4-(2,3-difluoro-4-methylphenyl)-1H-1,2,3-triazol-1- yl)-6-((1-((1S,3S)-3-hydroxy-1-methylcyclobutyl)-1H-1,2,3-triazol-4- yl)methyl)-2-(hydroxymethyl)-5-methoxytetrahydro-2H-pyran-3-ol::US20240109930, Example 1.1.19.

SMILES CO[C@H]1[C@@H](Cc2cn(nn2)[C@]2(C)C[C@H](O)C2)O[C@H](CO)[C@H](O)[C@@H]1n1cc(nn1)-c1ccc(C)c(F)c1F

InChI Key InChIKey=VRYXPUVEHNKGIJ-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 664432   

TargetGalectin-1(Human)
Idorsia Pharmaceuticals

US Patent
LigandPNGBDBM664432(US20240109930, Example 1.1.19. | (2R,3R,4S,5R,6R)-...)
Affinity DataIC50: 670nMAssay Description:Briefly, compounds are serially diluted in DMSO (working dilutions). ASF-coated 384well plates are supplemented with 22.8 μL/well of biotinylate...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2024
Entry Details
Go to US Patent

TargetGalectin-3(Human)
Idorsia Pharmaceuticals

US Patent
LigandPNGBDBM664432(US20240109930, Example 1.1.19. | (2R,3R,4S,5R,6R)-...)
Affinity DataIC50: 20nMAssay Description:Briefly, compounds are serially diluted in DMSO (working dilutions). ASF-coated 384well plates are supplemented with 22.8 μL/well of biotinylate...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2024
Entry Details
Go to US Patent